XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
24.61
-0.27 (-1.09%)
Aug 1, 2025, 4:00 PM - Market closed

Company Description

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific.

It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates.

The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.

It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024.

XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

XOMA Royalty Corporation
XOMA Royalty logo
CountryUnited States
Founded1981
IndustryBiotechnology
SectorHealthcare
Employees13
CEOOwen Hughes

Contact Details

Address:
2200 Powell Street, Suite 310
Emeryville, California 94608
United States
Phone510 204 7200
Websitexoma.com

Stock Details

Ticker SymbolXOMA
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0000791908
CUSIP Number98419J206
ISIN NumberUS98419J2069
Employer ID52-2154066
SIC Code2834

Key Executives

NamePosition
Owen P. Hughes Jr.Chief Executive Officer and Director
Thomas M. BurnsSenior Vice President of Finance and Chief Financial Officer
Bradley SitkoChief Investment Officer

Latest SEC Filings

DateTypeTitle
Jul 29, 2025SCHEDULE 13GFiling
Jun 6, 2025SCHEDULE 13G/AFiling
May 30, 20258-KCurrent Report
May 20, 2025SCHEDULE 13D/AFiling
May 13, 202510-QQuarterly Report
May 13, 20258-KCurrent Report
May 7, 2025SCHEDULE 13GFiling
Apr 15, 2025ARSFiling
Apr 15, 2025DEF 14AOther definitive proxy statements
Apr 4, 2025PRE 14AOther preliminary proxy statements